S. 340 · 116th Congress
A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
- Stage
- Introduced
- Sponsor
- Patrick Leahy
- Introduced
- 2019-02-05
- Latest action
- 2019-02-06 · Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
Votes
No linked votes are available for this bill.